West Pharmaceutical Services Stock Hits New 52-Week High (WST)

NEW YORK ( TheStreet) -- West Pharmaceutical Services (NYSE: WST) hit a new 52-week high Wednesday as it is currently trading at $48.46, above its previous 52-week high of $48.39 with 110,841 shares traded as of 3:59 p.m. ET. Average volume has been 167,300 shares over the past 30 days.

West Pharmaceutical Services has a market cap of $1.61 billion and is part of the health care sector and health services industry. Shares are up 26.7% year to date as of the close of trading on Tuesday.

West Pharmaceutical Services, Inc. manufactures and sells components and systems for injectable drug delivery and plastic packaging, and delivery system components for the pharmaceutical, healthcare, and consumer products industries. The company has a P/E ratio of 19.7, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates West Pharmaceutical Services as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, compelling growth in net income, attractive valuation levels and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. You can view the full West Pharmaceutical Services Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

West Pharmaceutical (WST) Stock Stumbling, Wells Fargo Downgrades

2 Big Companies and 1 Small One to Target in the Pharma/Biotech Space

Strong And Under The Radar Today: West Pharmaceutical Services (WST)

Dividend Watch: 3 Stocks Going Ex-Dividend Monday: HRZN, GHC, WST

Don't Miss Today's Strong And Under The Radar Stock: West Pharmaceutical Services (WST)